Role of Lifestyle and Oral Anti-Diabetic Agents to Prevent Type 2 Diabetes Mellitus and Cardiovascular Disease
- 1 March 2007
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 99 (5) , 726-731
- https://doi.org/10.1016/j.amjcard.2006.09.122
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Cardiovascular Therapies and Risk for Development of DiabetesJournal of the American College of Cardiology, 2004
- Is the Current Definition for Diabetes Relevant to Mortality Risk From All Causes and Cardiovascular and Noncardiovascular Diseases?Diabetes Care, 2003
- Effects of the Amount and Intensity of Exercise on Plasma LipoproteinsNew England Journal of Medicine, 2002
- Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)BMJ, 2001
- Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteriaThe Lancet, 1999
- The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.Diabetes Care, 1999
- Intensity and Amount of Physical Activity in Relation to Insulin SensitivityJAMA, 1998
- Glucose: a Continuous Risk Factor for Cardiovascular DiseaseDiabetic Medicine, 1997
- Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes StudyDiabetes Care, 1997
- U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive DiseaseDiabetes, 1995